KOS PHARMACEUTICALS INC 4
4 · KOS PHARMACEUTICALS INC · Filed May 23, 2005
Insider Transaction Report
Form 4
KIRITSY CHRISTOPHER P
Executive VP and CFO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2005-05-20−5,000→ 51,500 totalExercise: $19.50Exp: 2013-01-22→ Common Stock (5,000 underlying) - Sale
Common Stock, $.01 Par Value
2005-05-20$55.00/sh−5,000$275,000→ 3,000 total - Exercise/Conversion
Common Stock, $.01 Par Value
2005-05-20$19.50/sh+5,000$97,500→ 8,000 total
Footnotes (3)
- [F1]Includes one share jointly owned with spouse.
- [F2]Includes 2,999 shares of Kos common stock acquired by reporting person in transactions exempt under Section 16 of the Exchange Act under the Kos 401(k) plan and the Employee Stock Purchase Plan.
- [F3]Part of an original grant of 85,000 options, exercisable in the following amounts on the following exercise dates: 21,250 on January 23, 2004 21,250 on January 23, 2005 21,250 on January 23, 2006 21,250 on January 23, 2007